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Abstract
Although epidemiological and functional studies have implicated NK cells in protection and early clearance of HCV, the
mechanism by which they may contribute to viral control is poorly understood, particularly at the site of infection, the liver.
We hypothesized that a unique immunophenotypic/functional NK cell signature exists in the liver that may provide insights
into the contribution of NK cells to viral control. Intrahepatic and blood NK cells were profiled from chronically infected
HCV-positive and HCV-negative individuals. Baseline expression of activating and inhibitory receptors was assessed, as well
as functional responses following stimulation through classic NK cell pathways. Independent of HCV infection, the liver was
enriched for the immunoregulatory CD56bright NK cell population, which produced less IFNc and CD107a but comparable
levels of MIP1b, and was immunophenotypically distinct from their blood counterparts. This profile was mostly unaltered in
chronic HCV infection, though different expression levels of NKp46 and NKG2D were associated with different grades of
fibrosis. In contrast to the liver, chronic HCV infection associated with an enrichment of CD161lowperforinhigh NK cells in the
blood correlated with increased AST and 2B4 expression. However, the association of relatively discrete changes in the NK
cell phenotype in the liver with the fibrosis stage nevertheless suggests an important role for the NK response. Overall these
data suggest that tissue localization has a more pervasive effect on NK cells than the presence of chronic viral infection,
during which these cells might be mostly attuned to limiting immunopathology. It will be important to characterize NK cells
during early HCV infection, when they should have a critical role in limiting infection.
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Introduction
Chronic Hepatitis C virus (HCV) infection is a major health
care burden, with 150–170 million people chronically infected
worldwide. Traditional treatment protocols are burdened with
side-effects and only effective in ,50% of cases [1], and although
effective new medications have recently become available, these
are very costly and thus the need for a protective vaccine against
HCV remains [2,3]. However, approaches focused on inducing
effective T cell responses [2] or HCV-specific antibodies have had
limited success [4], thus research into the stimulation of innate
immune effectors as therapeutic or vaccine targets is warranted.
Natural killer (NK) cells are innate immune cells specialized in
the elimination of virus-infected cells. They account for up to 15%
of peripheral blood lymphocytes and are prevalent at higher
frequencies in tissues such as the liver [5]. They can be divided
into functionally distinct subsets based on their level of CD56
surface expression: the mainly cytotoxic CD56dim population and
the more immunoregulatory cytokine-producing CD56bright NK
cell subset. While these subsets account for 90% and 10% of total
NK cells in the peripheral blood respectively [6,7] these relative
frequencies are reversed in secondary lymphoid organs including
the liver, with the majority of NK cells CD56bright. The functions
of both NK cell subsets are modulated by inhibitory and activating
signals provided through distinct classes of receptors. The best
described of these include the killer cell immunoglobulin-like
receptors (KIR), the C-type lectins (NKG2), the activating natural
cytotoxicity receptors (NCR), and the FccRIIIa receptor (CD16)
that mediates antibody-dependent cytotoxicity [8]. Together,
these receptors modulate NK cell function to allow rapid targeting
and destruction of virally infected cells without the need for prior
sensitization, making them an important first line of defense
against viral pathogens.
NK cells may be particularly relevant in the setting of HCV
infection, a hepatotropic virus, given that NK cells account for up
to 50% of the liver-resident lymphocyte population [9]. Signifi-
cantly, epidemiological evidence has strongly linked enhanced
HCV clearance and sustained viral control with homozygosity of
PLOS ONE | www.plosone.org 1 August 2014 | Volume 9 | Issue 8 | e105950
the NK killer cell immunoglobulin-like receptor gene KIR2DL3
and its ligand HLA-C group 1 alleles [10–12]. Moreover,
immunophenotypic analyses of peripheral blood NK cells have
identified both a distinct NK cell profile in acute infection that
predicts HCV clearance [13] and altered NK cell profiles in
chronic infection [14–16], while more recently, NK cell modula-
tion of virus-specific T cells has been implicated in enhanced viral
clearance and reduced immunopathology in mouse models of
acute and chronic viral infection [17]. Therefore, changes in
specific NK cell subsets may dictate or contribute to disease
progression in HCV infection.
Despite the identification of NK cell profiles associated with
HCV in the peripheral blood, the key to understanding which cells
are most important in antiviral control is likely to lie in the liver,
given this is the site of viral replication. Moreover, as intra-hepatic
NK cell populations are phenotypically and functionally distinct
from those of the peripheral blood, it is likely that unique
signatures and functional subsets may contribute to the antiviral
response at this target site [18]. As such, the inclusion of HCV-
uninfected livers to control for tissue-specific differences is crucial
and has been lacking in the majority of studies, which to date have
reported conflicting results [15,16], underlining the uncertainty
regarding the effects of HCV infection on liver-resident NK cells
in chronic disease. Thus, here we sought to define novel NK cell
signatures in HCV-infected livers compared to matched blood
samples.
Materials and Methods
Subjects, cohort characteristics and sample preparation
Liver specimens were obtained from surgical resection of liver
tissue or liver explantation at the Massachusetts General Hospital
Gastrointestinal Unit and the Department of Surgery. When
intrahepatic lesions were present, the tissue was collected from the
most distant section of the specimen. We analyzed 9 HCV-positive
liver tissues with paired blood samples, 14 non-HCV diseased liver
tissues (six with paired blood samples), and eight blood samples
from healthy controls. Clinical characteristics of HCV-infected
individuals are described in Table 1, and the reason for liver
transplant in the HCV-uninfected individuals are described in
Table 2. Intrahepatic lymphocytes were extracted as previously
described [19].
Ethics statement
All subjects in this study provided written informed consent
prior to sampling. The study was conducted according to the
principles expressed in the declaration of Helsinki, and was
approved by the Partners Human Research Committee (Title:
‘Cell mediated immunity in Hepatitis C infection’. Protocol
#1999-P-004983/54; MGH #90-7246).
NK cell immunophenotyping
Flow cytometry was performed on cryopreserved cells. As per
the gating strategy in figure 1A, NK cells were identified using a
combination of Fixable blue dead cell stain (Life technologies),
CD3-Pacific Blue, CD56-PE-Cy7 and CD16- APC-Cy7 (BD
Biosciences). NK cell receptor expression was assessed using
combinations of CD158a-PerCP-Cy5.5 (eBioscience), CD158b-
FITC, KIR3DL1-Alexafluor700 (both Biolegend), KIR2DL3-PE,
KIR2DL1-APC (both R&D Systems), NKG2A-PE (Beckman
Coulter), NKG2D-APC, CD94-FITC, 2B4-FITC, NKp46-PE,
NKp30-APC (all BD Biosciences), TRAIL-PE (Biolegend),
CD161-FITC (Miltenyi) and CD160-Alexafluor647 (Biolegend).
For intracellular staining, cells were fixed and permeabilized
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(PermA/B solution, Caltag) according to the manufacturers’
instructions, prior to incubation with Perforin-PerCP-Cy5.5
(eBioscience). At least 1500 NK cells were acquired for all samples
on either a five laser BD LSRFortessa or a four laser BD LSRII
system, equipped with FACSDiva Version 8.8.3 (BD biosciences).
Rainbow beads ensured a consistent, comparable level of
fluorescence across all samples on different days of acquisition.
Gates were set using fluorescence minus one or unstimulated
samples where appropriate. The data were analysed using FlowJo
version 9.5.3 (Treestar, OR, USA).
Analysis of NK cell function
NK cell responses to target cell lines were determined as
previously described [13]. Briefly, mononuclear cells were
incubated with MHC class I-devoid K562, 721.221, or
antibody-coated p815 cell lines (ATCC) at an effector to target
ratio of 10:1. CD107a-PECy5 (10 ml/ml), brefeldin A (0.5 mg/
ml, Sigma-Aldrich) and monensin (0.5 mg/ml, GolgiStop; BD
Biosciences) were added at the start of the incubation. After five
hours, cells were washed and stained to identify NK cells as
above. Cells were fixed, permeabilized and stained for intracel-
lular cytokines using MIP1b-PE and IFNc-FITC (both BD
Biosciences) antibodies. Multi-parameter flow cytometry was
performed on a 4 laser BD LSRII system and analyzed as
above.
Statistical analyses
Descriptive measures (such as frequency, mean, median,
standard deviation and interquartile range) were used to
summarize data. The Mann-Whitney test was used for the
comparison of phenotype and functional data between two
groups. For more than two groups comparison, the Kruskal–
Wallis test with Dunn’s post hoc analyses was used. Spearman’s
rank correlation was used to examine bivariate associations. All P
values are two-sided and P values of ,0.05 were considered
significant. Statistical analyses were conducted using GraphPad
Prism (GraphPad Prism Software, La Jolla, CA). Heatmaps were
generated using Genepattern v3.8.0 (Broad Institute, Cambridge,
MA) and display colors based on relative values within each
phenotypic marker.
Results
Intrahepatic lymphocytes are enriched for CD56bright NK
cells independent of HCV infection
Similar to previous reports showing an enrichment of NK cells
in healthy liver compared to the peripheral blood [20,21], we
observed more NK cells in the liver of uninfected individuals
compared to the blood (25.27% vs. 9.8%, p,0.01, Figure 1B).
This difference was not seen in the setting of HCV infection,
though this has been suggested to be a consequence of relative
dilution due to T-cell infiltration [16,22] which is supported by the
increased T:NK cell ratio in HCV-infected livers (Figure 1B).
Given the altered distribution of the functionally distinct
CD56bright and CD56dim NK cell subsets in secondary lymphoid
tissues [18] and the liver [23], we next investigated whether these
populations were skewed in the context of HCV infection. As
described for other tissue-resident NK cells [18], we observed an
enrichment of the immunoregulatory CD56bright population over
the cytotoxic CD56dim population in the liver versus the blood of
both HCV-infected (p = 0.0005) and -uninfected (p,0.0001)
individuals (Figure 1C). This enrichment was striking, with
CD56bright NK cells accounting for up to 85% of the total NK
cell population in the liver of some individuals. However no
difference in the subset distribution was observed among infected
or uninfected subjects, demonstrating that certain NK cell
populations universally compartmentalize to the liver, which
remain relatively unperturbed in HCV infection.
Liver resident CD56bright NK cells display an altered
immunophenotype, independent of HCV infection
NK cell activation is governed by a complex interplay of
activating and inhibitory receptors [8,24] that may be perturbed in
the context of disease and tissue location [15,16,18,23]. Here we
observed an enrichment of NKG2D+, 2B4+ and CD160+ (97.4%
vs. 85.65%, p= 0.0011; 90.2% vs. 66.4%, p= 0.008; 90.2% vs.
17.8%, p,0.0001) CD56bright NK cells in the livers of HCV-
uninfected, and 2B4+ and CD160+ in HCV-infected individuals
(82.75% vs. 61.25%, p= 0.07; 88% versus 22%, p= 0.015) versus
the blood compartment (Figure 2A, Figures S3, S4). We also
observed a lower frequency of liver-resident NK cells expressing
NKp46 and NKp30 in both HCV-infected (54.55% vs. 91.4%,
p= 0.0063; 82.15% vs. 96.45%, p= 0.0058) and -uninfected
individuals (69.7% vs. 93.4%, p,0.0001; 76.3% vs. 95.7%, p,
0.0001, Figure 2A, S1), a phenotype previously associated with
recent NK cell activation [13,25]. Consistent with this, there was a
trend towards increased levels of spontaneous degranulation
(CD107a), another indicator of NK activation [16], in the liver
compared to the blood of HCV-infected individuals, which
reached statistical significance in HCV-uninfected individuals
(20.3% vs 1.85%, p= 0.0056, Figure 3A). Additionally, fewer NK
cells expressed the inhibitory receptor NKG2A, and the ADCC-
mediating receptor CD16 in the liver than in the blood in both
HCV-infected (73.15% vs. 83.08%, p= 0.025; 10.2% versus
33.45%, p= 0.0055; Figure 2A) and -uninfected individuals
(73.15% vs. 89.7%, p= 0.01: 9.9% versus 27.3%, p= 0.0005;
Figure 2A). Interestingly, there was also an enrichment of
CD161+ cells in the liver-resident CD56bright NK cell subset of
HCV-infected and -uninfected individuals (85.85% vs. 41.9%, p,
0.0001; 95.2% vs. 65.5%, p,0.0001, Figure 2A). Thus liver-
resident CD56bright NK cells exhibit an NCRlow, CD16low,
CD107ahigh, NKG2Dhigh, 2B4high, CD160high, CD161high, and
NKG2Alow phenotype, suggesting that NK cells are activated in
the liver, and surprisingly were not altered in the context of
chronic HCV infection.
Table 2. Reasons for liver surgery in non-HCV infected
individuals.
Number of Liver samples Reason for surgery
5 CRC metastasis
1 Primary biliary cirrhosis
2 Hepatocellular Carcinoma
1 AIH
1 Adenoma
1 Ileal cancer metastasis
1 Cryptogenic cirrhosis
1 Choledocholithiasis and recurrent
cholangitis
1 Oro-pharyngeal cancer metastasis
doi:10.1371/journal.pone.0105950.t002
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HCV-related liver differences are independent of cirrhosis
and liver inflammation
We next asked whether the presence of ongoing inflammation
or cirrhosis in the liver might be a confounder in detecting HCV-
associated NK cell changes. After stratifying for the presence of
cirrhosis, independent of HCV infection, we observed no
differences in the NK cell profile between these two groups
(Figure S1). Furthermore, the presence of ongoing inflammation
was not associated with altered frequencies of NK cell subsets, or
the majority of NK cell surface markers (Figure S2A, B). While
inflammation did impact the percentage of NK and T cells of total
lymphocytes and the frequency of CD56bright NK cells expressing
NKp30, exclusion of inflamed livers from the analysis did not alter
the HCV-associated profiles described here (Figure S2A, C, D),
suggesting that cirrhosis and liver inflammation were not
confounding factors in our study.
Liver NK cells have reduced cytotoxicity and ADCC
function compared to circulating NK cells
Given the limited differences observed in NK cell immunophe-
notypes in the livers of HCV-infected and uninfected patients, we
next sought to define whether liver-resident CD56bright NK cells
were functionally distinct from those in the blood in HCV
infection. NK cell function was assessed against a panel of target
Figure 1. NK cell subsets and distribution in liver and blood. NK cells were identified in the blood and liver of groups of HCV-infected and -
uninfected individuals by flow cytometry using a robust gating strategy (A). The size of the NK and T cell populations as a percentage of the total
lymphocyte population, as well as the T:NK cell ratio was calculated in the liver and blood in HCV-infected and -uninfected individuals (B), as was the
contribution of the CD56bright and CD56dim NK cell subsets to the total NK cell population (C). Statistical significance was accepted at p,0.05 and is
indicated by * (p,0.05), ** (p,0.01) and *** (p,0.001).
doi:10.1371/journal.pone.0105950.g001
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Figure 3. Tissue- and disease-specific differences in NK cell functionality. Functional responses of liver-resident and blood NK cells were
assessed in groups of HCV-infected and –uninfected individuals. NK cell degranulation (CD107a) and cytokine production (MIP1b and IFNc) were
measured by flow cytometry in the absence (A) or presence (B) of K562 cells (NKG2D ligation), 721.221 cells (NCR ligation) or antibody-coated p815
cells (ADCC-mediated stimulation). Statistical significance was accepted at p,0.05 and is indicated by * (p,0.05), ** (p,0.01), *** (p,0.001) and ****
(p,0.0001).
doi:10.1371/journal.pone.0105950.g003
Figure 2. Immunophenotypic profiles of blood and liver-resident NK cell subsets. Immunophenotyping of liver and blood NK cell subsets
in groups of HCV-infected and –uninfected individuals was performed by flow cytometry, and both tissue-specific differences (A) and disease-specific
differences (B) were analyzed. Data is presented as a heatmap, with values displayed as relative within each row. Statistical significance was accepted
at p,0.05 and is indicated by * (p,0.05), ** (p,0.01), *** (p,0.001) and **** (p,0.0001).
doi:10.1371/journal.pone.0105950.g002
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cells including an NKG2D-target cell line (K562), NCR-target cell
line (721.221) and an ADCC-target cell line (antibody-coated p815
cells). Overall, functional responses of liver-resident CD56bright
NK cells were distinct from those of the blood in both HCV-
infected and -uninfected individuals (Figure 3B). Specifically, in
uninfected individuals, compared to the blood, liver-resident
CD56bright NK cells exhibited reduced degranulation following
stimulation with ADCC and NKG2D targets (4.61% vs. 6.24%,
p= 0.0032; 0% vs. 9.83%, p= 0.0584) and impaired IFNc
production following stimulation with NKG2D targets (0.01%
vs. 1.63%, p= 0.014), while MIP1B production was maintained in
response to all stimuli. ADCC-mediated responses were consistent
with the expression of CD16 on CD56bright NK cells the frequency
of which significantly correlated with ADCC-mediated degranu-
lation and MIP1b production in the blood (Figure S5). When we
compared blood NK cells from HCV-infected and –uninfected
individuals we observed greater production of MIP1b following
NKG2D-mediated stimulation in HCV-infected individuals (18.38%
vs. 4.32%, p=0.045). The function of CD56dim NK cells showed
similar patterns (Figure S6). Thus, overall, liver NK cells appear less
functionally active than blood NK cells upon stimulation, and
consistent with the unaltered immunophenotype observed here
(Fig 2), remained unperturbed in the context of HCV infection, while
the ability of blood NK cells to selectively produce the chemo-
attractant MIP1b was enhanced with HCV infection.
High levels of NKp46 and NKG2D on CD56bright liver NK
cells is associated with low fibrosis
Despite observing limited alterations in the liver NK cell
immunophenotype and function in HCV infection, we investigated
whether a particular NK cell profile was linked to liver damage, given
that chronic HCV is associated with increased liver fibrosis and
incidence of cancer. We observed that CD56bright liver NK cells
expressing high levels of the activating receptors NKp46 and
NKG2D were inversely correlated with ISHAK score, a clinical
measure of liver fibrosis (r=20.9684, p,0.0001; r=20.778,
p=0.038; figure 4A), and that the frequency of NKG2D+CD56bright
NK cells in the liver was inversely correlated with serum bilirubin
(r=20.861, p=0.007; Figure 4A) which is a marker of liver
function, cholestasis and hemoglobin turnover. These data suggest
that NK cells are associated with altered liver function andmay play a
role in modulating liver fibrosis in chronic HCV infection.
HCV infection is linked to higher perforin expression and
lower frequency of CD161+ blood NK cells
Discrete NK cell patterns in the blood have previously been
reported in chronic HCV infection [14]. We therefore investigated
whether blood NK cells displayed a distinct HCV-specific profile
in our cohort. We observed a lower frequency of NK cells
expressing the inhibitory receptor CD161, and an enrichment of
perforin-expressing CD56bright NK cells in the blood of HCV-
infected versus -uninfected individuals (41.9% vs. 65.5%,
p= 0.012; 85.8% vs. 46.1%, p= 0.017, Figure 4B). This was
accompanied by higher expression of perforin on a per cell basis
(p = 0.014, data not shown), indicating that not only are there
more perforin-expressing NK cells in the blood of HCV-infected
individuals but that each of these cells contains more perforin. No
other differences in NK cell markers were observed in the blood
between HCV-infected and –uninfected individuals (Figure 2B).
This suggests that the inhibitory profile of blood NK cells and the
regulation of perforin may be altered in the context of chronic
HCV infection, and may result in a more cytolytic NK cell profile
following chronic exposure to inflammatory or viral signals.
PerforinhighCD161low blood NK cells are linked to liver
inflammation and altered activation profiles
In light of the clear enrichment of perforinhighCD161low cells in
the blood of HCV-infected individuals, we next aimed to
characterize the relationship between this population of NK cells
in HCV-infected subjects, and markers of disease pathology.
Interestingly, the frequency of CD161+ CD56bright NK cells in the
blood was inversely correlated with serum levels of aspartate
aminotransferase (AST, r =20.8, p = 0.0138, Figure 4B), a liver
enzyme associated with acute liver damage, suggesting there may
be an association of these cells with liver inflammation. Moreover,
expression of perforin was associated with elevated 2B4 expression
(r = 0.75, p = 0.0149) in the CD56bright NK cell subset (Figure 4C).
In contrast to HCV infected individuals, perforin expression was
inversely correlated with 2B4 expression (r =20.68, p = 0.0251)
suggesting that HCV infection may significantly alter the
relationship between these molecules, resulting in the expansion
of a unique population of NK cells in the blood marked by
perforinhighCD161low2B4highCD56bright.
Discussion
Mounting evidence supports a role for NK cells in antiviral
control of HCV [10,13,26–29], yet the majority of studies to date
have focused on the activity of blood NK cells, and only a few
studies have probed the NK cell response at the site of infection,
the liver. Furthermore, previous reports published on the
properties of intrahepatic NK cells are conflicting, likely related
to limited cell numbers from biopsies or lack of appropriate
controls [15,16,30,31]. Therefore, here we aimed to carefully
characterize blood and liver NK cells from both HCV-infected
and -uninfected donors from whom intrahepatic cells were
obtained following liver surgery (Tables 1, 2). We observed that
the liver, like other organs [18] was enriched for CD56bright NK
cells, which exhibited an activated profile, marked by NCRlow
NKG2AlowCD107ahighCD160highNKG2Dhigh and displayed sup-
pressed ADCC- and NKG2D-mediated recognition of target cells.
Interestingly, the liver-resident NK cell immunophenotype
appeared unperturbed in the context of chronic HCV infection,
whereas more striking differences were observed in the blood,
marked by the expansion of a CD161lowperforinhigh NK cell
population. These data surprisingly show NK cell phenotypes and
functions in the liver that are relatively preserved in the presence
of chronic HCV infection, while a stronger impact is observed in
circulating NK cells.
A key difference between liver-resident NK cells and those from
the blood in all cases, irrespective of liver pathology, was reduced
NCR expression. Activation of NK cells results in rapid
downregulation of NKp46 and NKp30 through the action of
matrix metalloproteinase [13,25,32], possibly as a mechanism of
avoiding activation-induced cell death, and therefore represents a
potential marker of recent activation. Furthermore, liver NK cells
exhibited dampened NKG2D- and ADCC-mediated antiviral
function while production of the chemoattractant cytokine MIP1b
was maintained, independent of infection, demonstrating selective
inhibition of cytolytic NK cell activity within this tissue. However,
the liver appears to be a naturally immunosuppressed environment
[33] requiring specific signals, such as interferons [34], to elicit
cytolytic responses in the presence of classic activating signals [35].
Thus, functional differences between liver and blood NK cells
should perhaps be expected, as the suppression of NK cell
responses through specific pathways may be important in
preventing excessive liver damage during infection, while chemo-
kine secretion may permit the effective or enhanced recruitment of
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other effector cells to the sites of infection to effectively control
viral replication. Thus, while the studies presented here were
performed on limited numbers of samples, they provide evidence
for a distinct functional signature of NK cells in the liver, which
may warrant future studies on larger patient populations.
Interestingly, the profile of intrahepatic NK cells was remark-
ably unaltered in chronic HCV infection. This was in contrast to
previous reports demonstrating distinct NK cell profiles in blood
[14] and liver [15,16]. Specifically, Nattermann et al (2006)
demonstrated that differences could be successfully identified in a
relatively small cohort. However, sufficient statistical power existed
in the study detailed here to resolve significant differences in NK
cell phenotypic differences, and lack of concordance with previous
studies likely reflects differences in biopsy collection from subjects
at divergent stages of disease. Further studies using larger patient
cohorts may however provide greater opportunity in the
identification of more subtle differences in NK cell phenotype
and function in the liver at different stages of the disease.
In our cohort we observed that high levels of the activating
receptors NKp46 and NKG2D tracked with lower liver fibrosis and
function. This has previously been shown for NKp46 [36] linked to
efficient NK cell mediated killing of stellate cells [37], suggesting that
the enrichment of these cells in the liver may help control fibrosis.
Moreover, the relative lack of NK cell perturbation in the liver in
Figure 4. Unique liver and blood NK phenotypes associate with markers of disease progression. Correlative analysis of NK cell
immunophenotype and function in the liver and blood with clinical measures of HCV infection such as ISHAK score, ALT, AST, serum bilirubin, HCV
RNA and INR were performed. The significant associations of liver NK cell receptors with clinical markers are displayed (A) along with correlations
between the frequency of CD161+, (B) and perforin expression on blood CD56bright NK cells (C) with clinical markers and the expression of other NK
cell receptors. Correlations were done using Spearman’s rank test and statistical significance was accepted at p,0.05 and is indicated by * (p,0.05),
** (p,0.01) and *** (p,0.001).
doi:10.1371/journal.pone.0105950.g004
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chronic HCV infection may not be surprising given that NK cells are
typically involved in the initial innate immune response to acute viral
infections. As such, it is plausible that studies on liver samples from
chronically infected subjects may have missed the window of time
when the most robust waves of NK cell responses may be elicited.
Therefore, in sampling during chronic infection, we may be looking
at a cell population geared towards limiting fibrosis rather than viral
suppression. Thus, future studies should focus on acutely infected
subjects that either go on to resolve infection or develop chronic HCV
disease. This should be feasible through the employment of elective
fine needle aspirates from the liver [38,39] and should provide
insights into the nature of NK cell responses that do or do not control
viremia.
In contrast to the liver, we observed a distinct NK cell profile in
the blood that tracked with HCV infection and was characterized
by low frequencies of CD161+ cells and high levels of perforin in
the CD56bright population. Reduced frequencies of CD161+ NK
cells have previously been observed in chronic HCV and HIV
infection [13,28] suggesting that cells with this specific phenotype
respond to HCV infection. Interestingly, we found an inverse
relationship between the frequency of CD161+ CD56bright NK
cells and levels of serum AST in our cohort, suggesting a link
between this marker and increased inflammation in the liver. As
such, liver inflammation could drive increased homing of CD161+
NK cells to the liver. However, we observed no increase in the
frequency of CD161+ NK cells in the liver in HCV infection,
raising the question whether these cells might ultimately get
deleted in high-level viremia that persists for many years.
Alternatively, long-term exposure to inflammatory signals may
result in downregulation of the inhibitory CD161 receptor on
CD56bright NK cells, resulting in a more activated NK cell
population in chronic disease. Moreover, elevated perforin
expression in CD56bright NK cells in HCV infection was associated
with a distinct 2B4high immunophenotype. Perforin is an
important cytolytic molecule and its elevation in chronic HCV
infection may suggest increased cytolytic potency of blood NK
cells, potentially driven by chronic inflammatory signals. Conse-
quently, perforin-mediated mechanisms of NK cell killing may be
boosted in chronic HCV infection. Interestingly, T cell are major
drivers of liver fibrosis in HCV infection [40] and recent evidence
has shown that in the setting of chronic infection, perforin-
mediated modulation of virus-specific T cell responses by NK cells
is crucial in limiting liver damage [17,41–44]. Moreover, the key
NK cell receptor involved in this mechanism was 2B4 [17,45],
suggesting that the altered relationship we observed between 2B4
and perforin in chronic HCV infection to be indicative of blood
NK cells tuned towards modulation of T cell responses in chronic
disease, rather than direct suppression of viral replication, with the
goal of limiting immunopathology.
Overall, we demonstrate that tissue localization is the dominant
factor influencing NK phenotype and functional profiles. Surprising-
ly, HCV infection more broadly impacts the profiles of NK cells
circulating in the blood, compared to those in the liver. Yet subtle
differences in NK cell phenotype in the liver were associated with
distinct clinical outcomes, suggesting that in chronic infection,
intrahepatic NK cells may be functionally tuned towards modulating
immunopathology, rather than limiting viral replication. Additional
studies, on liver-resident NK cells during acute infection, a time when
innate immune cellular activity may be most relevant, could provide
greater insights into the role of this cytolytic lymphocyte subset, which
may be a critical component of early antiviral immunity.
Supporting Information
Figure S1 Intrahepatic NK cell profiles in cirrhotic
livers. Box plots comparing the frequency of (A) NK and T cells,
NK cell subsets and (B) expression of NK cell receptors on resting
intrahepatic CD56bright NK cells, as well as K562-stimulated
functional responses (CD107a, IFNc and MIP1b production),
stratified by the presence or absence of cirrhosis.
(TIF)
Figure S2 Intrahepatic NK cell profiles in inflamed
livers. Box plots comparing the frequency of (A) NK and T cells,
NK cell subsets and (B) expression of NK cell receptors on resting
intrahepatic CD56bright NK cells, stratified by the presence or
absence of ongoing liver inflammation. (C) Comparison of NKp30
expression on intrahepatic CD56bright NK cells in the presence or
absence of liver inflammation and, following exclusion of inflamed
livers, in the presence or absence of HCV infection. (D) Comparison
of percentage of NK cells and T cells of total lymphocytes in presence
of absence of HCV infection following exclusion of inflamed livers.
(AI)
Figure S3 Key tissue and disease specific CD56bright NK
cell differences. Scatter plots showing the significant immuno-
phenotypic differences between blood and liver-resident CD56bright
NK cell populations in groups of HCV-infected and uninfected
individuals. Statistical significance was accepted at p,0.05 and is
indicated by * (p,0.05), ** (p,0.01) and *** (p,0.001).
(TIF)
Figure S4 Representative FACS plots of phenotypic NK
cell receptors. Representative flow cytometry plots showing the
key immunophenotypic differences between blood and liver-resident
CD56bright NK cell populations in groups of HCV-infected and
uninfected individuals.
(TIF)
Figure S5 CD16 expression on CD56bright NK cells and
ADCC-mediated functionality. Representative flow cytome-
try plots show gating on the CD56bright population and
identification of the CD16+ subset (A). Following stimulation with
antibody-coated p815 cells, the function of CD56bright NK cells
was assessed by flow cytometry (B). Baseline expression of CD16
on the CD56bright population in the liver and blood of HCV-
infected and uninfected patients was assessed (C). CD56bright NK
cell function correlated with the frequency of CD16+ cells (D).
Statistical significance was accepted at p,0.05 and is indicated by
* (p,0.05), ** (p,0.01), *** (p,0.001) and **** (p,0.0001).
(TIF)
Figure S6 Tissue- and disease-specific differences in
CD56dim NK cell functionality. Functional responses of liver-
resident and blood CD56dim NK cells were assessed in groups of
HCV-infected and –uninfected individuals. NK cell degranulation
(CD107a) and cytokine production (MIP1b and IFNc) were
measured by flow cytometry in the absence (A) or presence (B) of
K562 cells (NKG2D ligation), 721.221 cells (NCR ligation) or
antibody-coated p815 cells (ADCC-mediated stimulation). Statis-
tical significance was accepted at p,0.05 and is indicated by * (p,
0.05), ** (p,0.01), *** (p,0.001) and **** (p,0.0001).
(TIF)
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